17522559

Source:http://linkedlifedata.com/resource/pubmed/id/17522559

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0085631, umls-concept:C0299792, umls-concept:C0442117, umls-concept:C2587213
pubmed:issue	3
pubmed:dateCreated	2007-5-24
pubmed:abstractText	To evaluate response to intramuscular (IM) aripiprazole injections using secondary analyses from clinical trials.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/17522559-17522556
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/100901141
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antipsychotic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Haloperidol, http://linkedlifedata.com/resource/pubmed/chemical/Hypnotics and Sedatives, http://linkedlifedata.com/resource/pubmed/chemical/Lorazepam, http://linkedlifedata.com/resource/pubmed/chemical/Piperazines, http://linkedlifedata.com/resource/pubmed/chemical/Quinolones, http://linkedlifedata.com/resource/pubmed/chemical/aripiprazole
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	1527-4160
pubmed:author	pubmed-author:CitromeLeslie LLL, pubmed-author:CrandallDavid TDT, pubmed-author:CurrierGlenn WGW, pubmed-author:ManosGeorgeG, pubmed-author:McQuadeRobertR, pubmed-author:OrenDanD, pubmed-author:PikalovAndrei AAA3rd, pubmed-author:ZimbroffDan LDL
pubmed:issnType	Print
pubmed:volume	13
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	159-69
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:17522559-Adult, pubmed-meshheading:17522559-Antipsychotic Agents, pubmed-meshheading:17522559-Arousal, pubmed-meshheading:17522559-Bipolar Disorder, pubmed-meshheading:17522559-Dose-Response Relationship, Drug, pubmed-meshheading:17522559-Double-Blind Method, pubmed-meshheading:17522559-Drug Administration Schedule, pubmed-meshheading:17522559-Female, pubmed-meshheading:17522559-Haloperidol, pubmed-meshheading:17522559-Humans, pubmed-meshheading:17522559-Hypnotics and Sedatives, pubmed-meshheading:17522559-Injections, Intramuscular, pubmed-meshheading:17522559-Lorazepam, pubmed-meshheading:17522559-Male, pubmed-meshheading:17522559-Middle Aged, pubmed-meshheading:17522559-Multicenter Studies as Topic, pubmed-meshheading:17522559-Piperazines, pubmed-meshheading:17522559-Psychiatric Status Rating Scales, pubmed-meshheading:17522559-Psychomotor Agitation, pubmed-meshheading:17522559-Quinolones, pubmed-meshheading:17522559-Randomized Controlled Trials as Topic, pubmed-meshheading:17522559-Schizophrenia, pubmed-meshheading:17522559-Schizophrenic Psychology, pubmed-meshheading:17522559-Treatment Outcome
pubmed:year	2007
pubmed:articleTitle	Intramuscular aripiprazole in the control of agitation.
pubmed:affiliation	Department of Psychiatry, University of Rochester Medical Center, Rochester, NY 14642, USA. glenn_currier@urmc.rochester.edu
pubmed:publicationType	Journal Article, Comparative Study